Treatment of Intracranial Atherosclerotic Stenoses

  • Wiebke KurreEmail author
  • Hansjörg Bäzner
  • Hans Henkes


Intracranial atherosclerosis is the most important cause of stroke worldwide. A thorough knowledge of this disease is necessary to establish the best treatment strategy for each individual patient.

This chapter briefly outlines epidemiological data and the natural history of intracranial atherosclerotic disease. Methods to establish the diagnosis are highlighted, and their advantages and disadvantages are discussed. The main focus is medical and endovascular treatment of patients with symptomatic intracranial atherosclerotic stenosis. Because endovascular treatment is a potentially harmful procedure and incorrect management might increase the risk, patient selection for endovascular treatment, procedural management, and follow-up are comprehensively discussed.


  1. 1.
    Abou-Chebl A, Krieger DW, Bajzer CT, et al. Intracranial angioplasty and stenting in the awake patient. J Neuroimaging. 2006;16:2016–223.CrossRefGoogle Scholar
  2. 2.
    Abou-Chebl A, Reginelli J, Bajzer CT, et al. Intensive treatment of hypertension decreases the risk of hyperperfusion and intracerebral hemorrhage following carotid artery stenting. Catheter Cardiovasc Interv. 2007;69:690–6.CrossRefPubMedGoogle Scholar
  3. 3.
    Akbari SH, Reynolds MR, Kadkhodayan Y, et al. Hemorrhagic complications after prasugrel (Effient) therapy for vascular neurointerventional procedures. J Neurointervent Surg. 2013;5:337–43.CrossRefGoogle Scholar
  4. 4.
    Al-Ali F, Cree T, Duan L, et al. How effective is endovascular intracranial revascularization in stroke prevention? Results from Borgess medical center intracranial revascularization registry. Am J Neuroradiol. 2011;32:1227–12331.CrossRefPubMedGoogle Scholar
  5. 5.
    Albuquerque FC, Levy EI, Turk AS, et al. Angiographic patterns of wingspan in-stent restenosis. Neurosurgery. 2008;63:23–8.CrossRefPubMedGoogle Scholar
  6. 6.
    Alexandrov AV, Demchuk AM, Burgin WS. Insonation method and diagnostic flow signatures for transcranial power motion (M-mode) Doppler. J Neuroimaging. 2002;12:236–44.CrossRefPubMedGoogle Scholar
  7. 7.
    Alurkar A, Karanam LS, Oak S, et al. Role of balloon-expandable stents in intracranial atherosclerotic disease in a series of 182 patients. Stroke. 2013;44:2000–3.CrossRefPubMedGoogle Scholar
  8. 8.
    Arenillas JF, Molina CA, Montaner J. Progression and clinical recurrence of symptomatic middle cerebral artery stenosis. Stroke. 2001;32:2898–904.CrossRefPubMedGoogle Scholar
  9. 9.
    Arkuszewski M, Swiat M, Hurst RW, et al. Vertebral and basilar arteries: transcranial color-coded duplex ultrasonography versus conventional TCD in detection of narrowings. Neuroradiol J. 2012;25:509–14.CrossRefPubMedGoogle Scholar
  10. 10.
    Bash S, Villablanca JP, Jahan R, et al. Intracranial vascular stenosis and occlusive disease: evaluation with CT angiography, MR angiography, and digital subtraction angiography. Am J Neuroradiol. 2005;26:1012–21.PubMedGoogle Scholar
  11. 11.
    Baumgartner RW, Arnold M, Gönner F, et al. Contrast-enhanced transcranial color coded duplex sonography in ischemic cerebrovascular disease. Stroke. 1997;28:2473–8.CrossRefPubMedGoogle Scholar
  12. 12.
    Brunser AM, Lavados PM, Hoppe A, et al. Accuracy of transcranial Doppler compared with CT angiography in diagnosing arterial obstructions in acute ischemic strokes. Stroke. 2009;40:2037–41.CrossRefPubMedGoogle Scholar
  13. 13.
    Chamzuk AJ, Ogilvy CS, Snyder KV, et al. Elective stenting for intracranial stenosis under conscious sedation. Neurosurgery. 2010;67:1189–93.CrossRefGoogle Scholar
  14. 14.
    Chaturvedi S, Turan TN, Lynn MJ, et al. Risk factor status and vascular events in patients with symptomatic intracranial stenosis. Neurology. 2007;69:2063–8.CrossRefPubMedGoogle Scholar
  15. 15.
    Chen XY, Wong KS, Lam WWM, et al. Middle cerebral artery atherosclerosis: histological comparison between plaques associated with and not associated with infarct in a postmortem study. Cerebrovasc Dis. 2008;25:74–80.CrossRefPubMedGoogle Scholar
  16. 16.
    Chimowitz MI, Lynn MJ, Howlett-Smith H, et al. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med. 2005;352:1305–16.CrossRefPubMedGoogle Scholar
  17. 17.
    Chimowitz MI, Lynn MJ, Derdeyn CP, et al. Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med. 2011a;365:993–1003.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Chimowitz MI, Lynn MJ, Turan TN, et al. Design of the stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis trial. J Stroke Cerebrovasc Dis. 2011b;20:357–68.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    De Silva DA, Woon F-P, Lee M-P, et al. South Asia patients with ischemic stroke. Intracranial large arteries are the predominant site of disease. Stroke. 2007;38:2592–4.CrossRefPubMedGoogle Scholar
  20. 20.
    Degnan AJ, Gallagher G, Teng Z, et al. MR angiography and imaging for the evaluation of middle cerebral artery disease. Am J Neuroradiol. 2012;33:1427–35.CrossRefPubMedGoogle Scholar
  21. 21.
    Delgado Almandoz JE, Kadkhodayan Y, Crandall BM, et al. Variability in initial response to standard clopidogrel therapy, delayed conversion to clopidogrel hyper-response, and associated thromboembolic and hemorrhagic complications in patients undergoing endovascular treatment of unruptured cerebral aneurysms. J Neurointervent Surg. 2014;6(10):767–73.CrossRefGoogle Scholar
  22. 22.
    Derdeyn CP, Fiorella D, Lynn MJ, et al. Mechanisms of stroke after intracranial angioplasty and stenting in the SAMMPRIS trial. Neurosurgery. 2013;72:777–95.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Derdeyn CP, Chimowitz MI, Lynn MJ, et al. Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial. Lancet. 2014;383:333–41.CrossRefPubMedGoogle Scholar
  24. 24.
    Derdeyn CP, Fiorella D, Lynn MJ, Turan TN, Cotsonis GA, Lane BF, Montgomery J, Janis LS, Chimowitz MI, and for the SAMMPRIS Investigators. Nonprocedural symptomatic infarction and in-stent restenosis after intracranial angioplasty and stenting in the sammpris trial (Stenting and aggressive medical management for the prevention of recurrent stroke in intracranial stenosis). Stroke. 2017;48:1501–6.CrossRefPubMedGoogle Scholar
  25. 25.
    Dewilde WJ, Oirbans T, Verheugt FW. Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial. Lancet. 2013;381:1107–15.CrossRefPubMedGoogle Scholar
  26. 26.
    Di Nicolantonio JJ, D’Ascenzo F, Tomek A, et al. Clopidogrel is safer than ticagrelor in regard to bleeds: a closer look at the PLATO trial. Int J Cardiol. 2013;168:1739–44.CrossRefGoogle Scholar
  27. 27.
    Famakin BM, Chimowitz MI, Lynn MJ, et al. Causes and severity of ischemic stroke in patients with symptomatic intracranial arterial stenosis. Stroke. 2009;40:1999–2003.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Feldmann E, Wilterding JL, Kosinski A, et al. The stroke outcomes and neuroimaging of intracranial atherosclerosis (SONIA) trial. Neurology. 2007;68:2099–106.CrossRefPubMedGoogle Scholar
  29. 29.
    Fifi JT, Brockington C, Narang J, et al. Clopidogrel resistance is associated with thromboembolic complications in patients undergoing neurovascular stenting. Am J Neuroradiol. 2013;34:457–63.CrossRefGoogle Scholar
  30. 30.
    Fiorella D, Levy EI, Turk AS, et al. Target lesion revascularization after Wingspan. Assessment of safety and durability. Stroke. 2009;40:106–10.CrossRefPubMedGoogle Scholar
  31. 31.
    Fiorella D, Derdeyn C, Lynn M, et al. Detailed analysis of periprocedural strokes in patients undergoing intracranial stenting in stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis (SAMMPRIS). Stroke. 2012;43:2682–8.CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    Goh C, Churilov L, Mitchell P, et al. Clopidogrel hyper-response and bleeding risk in neurointerventional procedures. Am J Neuroradiol. 2013;34:721–6.CrossRefPubMedGoogle Scholar
  33. 33.
    Gorelick PB, Wong KS, Bae HJ, et al. Large artery intracranial occlusive disease: a large worldwide burden but a relative neglected frontier. Stroke. 2008;39:2396–9.CrossRefPubMedGoogle Scholar
  34. 34.
    Hänggi D, et al. Neurosurgical revascularization for cerebral ischemic disease. In: Lanzer P, editor. Pan vascular medicine. Berlin, Heidelberg: Springer; 2015. p. 2823–33. ISBN 978-3-642-37079-3.CrossRefGoogle Scholar
  35. 35.
    Huang HW, Guo MH, Lin RJ, et al. Prevalence and risk factors of middle cerebral artery stenosis in asymptomatic residents in Ronqui County, Guangdong. Cerebrovasc Dis. 2007;24:111–5.CrossRefPubMedGoogle Scholar
  36. 36.
    Jiang WJ, Yu W, Du B, et al. Outcome of patients with ≥70% symptomatic intracranial stenosis after wingspan stenting. Stroke. 2011;42:1971–5.CrossRefPubMedGoogle Scholar
  37. 37.
    Jiang W, Cheng-Ching E, Abou-Chebl A, et al. Multicenter analysis of stenting in symptomatic intracranial atherosclerosis. Neurosurgery. 2012;70:25–31.CrossRefPubMedGoogle Scholar
  38. 38.
    Jin M, Fu X, Wei Y, et al. Higher risk of recurrent ischemic events in patients with intracranial in-stent restenosis. Stroke. 2013;44:2990–4.CrossRefPubMedGoogle Scholar
  39. 39.
    Joon KB, Hong KS, Cho YJ, et al. Predictors of symptomatic and asymptomatic intracranial atherosclerosis: what is different and why? J Atheroscler Thromb. 2014;21(6):605–17.Google Scholar
  40. 40.
    Kasner SE, Chimowitz MI, Lynn MJ, et al. Predictors of stroke in the territory of a symptomatic intracranial stenosis. Circulation. 2006;113:555–63.CrossRefPubMedGoogle Scholar
  41. 41.
    Kern R, Steinke W, Daffertshofer M, et al. Stroke recurrences in patients with symptomatic vs. asymptomatic middle cerebral artery disease. Neurology. 2005;65:859–64.CrossRefPubMedGoogle Scholar
  42. 42.
    Klötzsch C, Popescu O, Sliwka U, et al. Detection of stenoses in the anterior circulation using frequency based transcranial color-coded sonography. Ultrasound Med Biol. 2000;26:579–84.CrossRefPubMedGoogle Scholar
  43. 43.
    Krejza J, Mariak Z, Babikian VL, et al. Importance of angle correction in the measurement of blood flow velocity with transcranial Doppler sonography. Am J Neuroradiol. 2001;22:1743–7.PubMedGoogle Scholar
  44. 44.
    Kurre W, Berkefeld J, Brassel F, et al. In-hospital complication rates after stent treatment of 388 symptomatic intracranial stenoses: results from the INTRASTENT multicentric registry. Stroke. 2010;41:494–8.CrossRefPubMedGoogle Scholar
  45. 45.
    Kurre W, Brassel F, Brüning R, et al. Complication rated using balloon-expandable and self-expanding stents for the treatment of intrcranial atherosclerotic stenoses. Neuroradiology. 2012;54:43–50.CrossRefPubMedGoogle Scholar
  46. 46.
    Kurre W, Aguilar-Perez M, Fischer S et al (2013) Solving the issue of restenosis after stenting of intracranial stenoses: experience with two thin strut drug-eluting stents (DES) – Taxus element (Boston Scientific) and resolute integrity (Medtronic Inc.), oral presentation at the 37th ESNR annual meeting, Frankfurt.Google Scholar
  47. 47.
    Kwon SU, Cho YJ, Koo JS, et al. Cilostazol prevents the progression of the symptomatic intracranial arterial stenosis: the multicenter double-blind placebo-controlled trial of cilostazol in symptomatic intracranial arterial stenosis. Stroke. 2005;36:782–6.CrossRefPubMedGoogle Scholar
  48. 48.
    Kwon SU, Hong KS, Kang DW, et al. Efficacy and safety of combination antiplatelet therapies in patients with symptomatic intracranial atherosclerotic stenosis. Stroke. 2011;42:2883–90.CrossRefPubMedGoogle Scholar
  49. 49.
    Lau AY, Zhao Y, Chen C, et al. Dual antiplatelets reduce microembolic signals in patients with transient ischemic attack and minor stroke: subgroup analysis of CLAIR study. Int J Stroke. 2014;Suppl A100:127–32.CrossRefGoogle Scholar
  50. 50.
    Levine GN, Bates ER, Blankenship JC, et al. 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: executive summary. Catheter Cardiovasc Interv. 2012;79:453–95.CrossRefPubMedGoogle Scholar
  51. 51.
    Levy EI, Turk AS, Albuquerque FC, et al. Wingspan in-stent restenosis and thrombosis: incidence, clinical presentation, and management. Neurosurgery. 2007;61:644–51.CrossRefPubMedGoogle Scholar
  52. 52.
    Liebeskind DS, Kosinski AS, Lynn MJ, et al. Noninvasive fractional flow in MRA predicts stroke risk of intracranial stenosis. J Neuroimaging. 2015;25(1):87–91.CrossRefPubMedGoogle Scholar
  53. 53.
    López-Cancio E, Dorado L, Milán M, et al. The Barcelona-asymptomatic intracranial atherosclerosis (AsIA) study: prevalence and risk factors. Atherosclerosis. 2012;221:221–5.CrossRefPubMedGoogle Scholar
  54. 54.
    Markus HS, Harrison MJ. Estimation of cerebrovascular reactivity using transcranial Doppler, including the use of breath-holding as the vasodilatatory stimulus. Stroke. 1992;23:668–73.CrossRefPubMedGoogle Scholar
  55. 55.
    Mazighi M, Tanasescu R, Ducrocq X, et al. Prospective study of symptomatic atherothrombotic intracranial stenoses. The GESICA study. Neurology. 2006;66:1187–91.CrossRefPubMedGoogle Scholar
  56. 56.
    Muller M, Voges M, Piepgras U, et al. Assessment of cerebral vasomotor reactivity by transcranial Doppler ultrasound and breath-holding. A comparison with acetazolamide as vasodilatatory stimulus. Stroke. 1995;26:96–100.Google Scholar
  57. 57.
    Müller-Schunk SL, Peters N, Spannagl M, et al. Monitoring of Clopidogrel-related platelet inhibition: correlation of nonresponse with clinical outcome in supra-aortic stenting. Am J Neuroradiol. 2008;29:786–91.CrossRefPubMedGoogle Scholar
  58. 58.
    Nahab F, Lynn MJ, Kasner SE. Risk factors associated with major cerebrovascular complications after intracranial stenting. Neurology. 2009;72:2014–9.CrossRefPubMedPubMedCentralGoogle Scholar
  59. 59.
    Nguyen-Huynh MN, Wintermark M, English J, et al. How accurate is CT angiography in evaluating intracranial atherosclerotic disease? Stroke. 2008;39:1184–8.CrossRefPubMedGoogle Scholar
  60. 60.
    Ovbiagele B, Cruz-Flores S, Lynn MJ, et al. Early stroke risk after transient ischemic attack among individuals with symptomatic intracranial artery stenosis. Arch Neurol. 2008;65:733–7.CrossRefPubMedGoogle Scholar
  61. 61.
    Prabhakaran S, Wells KR, Lee VH, et al. Prevalence and risk factors for clopidogrel resistance in cerebrovascular stenting. Am J Neuroradiol. 2008;29:281–5.CrossRefPubMedGoogle Scholar
  62. 62.
    Psychogios MN, Schramm P, Buhk JH, et al. Angiographic CT after intravenous contrast application: a noninvasive follow-up tool after intracranial angioplasty and stenting. Am J Neuroradiol. 2010;31:1886–91.CrossRefPubMedGoogle Scholar
  63. 63.
    Psychogios MN, Schramm P, Amelung N, et al. Evaluation of noninvasive follow-up methods for the detection of intracranial in-stent restenosis: a phantom study. Investig Radiol. 2013;48:98–103.CrossRefGoogle Scholar
  64. 64.
    Pu Y, Liu L, Wang Y, et al. Geographic and sex differences in the distribution of intracranial atherosclerosis in China. Stroke. 2013;44:2109–14.CrossRefPubMedGoogle Scholar
  65. 65.
    Qureshi A, Al-Senani FM, Husain S, et al. Intracranial angioplasty and stent placement after stenting and aggressive medical management for preventing stroke in intracranial stenosis (SAMMPRIS) trial: present state and future considerations. J Neuroimaging. 2012;22:1–13.CrossRefPubMedGoogle Scholar
  66. 66.
    Riedel CH, Zimmermann P, Jensen-Kondering U, et al. The importance of size – successful recanalization by intravenous thrombolysis in acute anterior stroke depends on thrombus length. Stroke. 2011;42:1775–7.CrossRefPubMedGoogle Scholar
  67. 67.
    Sacco RL, Kargman DE, Gu O, et al. Race–ethnicity and determinants of intracranial atherosclerotic cerebral infarction. The Northern Manhattan Stroke Study. Stroke. 1995;26:14–20.PubMedGoogle Scholar
  68. 68.
    Samaniego EA, Hetzel S, Thirunarayanan S, et al. Outcome of symptomatic atherosclerotic disease. Stroke. 2009;40:2983–7.CrossRefPubMedPubMedCentralGoogle Scholar
  69. 69.
    Sharma VK, Tsivgoulis G, Lao AY, et al. Noninvasive detection of diffuse intracranial disease. Stroke. 2007;38:3175–81.CrossRefPubMedGoogle Scholar
  70. 70.
    Siddiq F, Memom MZ, Vasquez G, et al. Comparison between primary angioplasty and stent placement for symptomatic intracranial atherosclerotic disease: meta-analysis of case series. Neurosurgery. 2009;65:1024–33.CrossRefPubMedGoogle Scholar
  71. 71.
    Siddiq F, Chaudry SA, Khatri R, et al. Rate of postprocedural stroke and death in SAMMPRIS trial-eligible patients treated with intracranial angioplasty and/or stent placement in practice. Neurosurgery. 2012;71:68–73.CrossRefPubMedGoogle Scholar
  72. 72.
    Song L, Li J, Gu Y. Drug-Eluting Vs. Bare metal stents for symptomatic vertebral artery stenosis. J Endovasc Ther. 2012;19:231–8.CrossRefPubMedGoogle Scholar
  73. 73.
    Swiercz M, Swiat M, Pawlak M, et al. Narrowing of the middle cerebral artery: artificial intelligence methods and comparison of transcranial color coded duplex sonography with conventional TCD. Ultrasound Med Biol. 2010;36:17–28.CrossRefPubMedGoogle Scholar
  74. 74.
    Takahashi W, Ohnuki T, Ide M, et al. Stroke risk of asymptomatic intra- and extracranial large artery disease in apparently healthy adults. Cerebrovasc Dis. 2005;22:263–70.CrossRefGoogle Scholar
  75. 75.
    Tsivgoulis G, Sharma VK, Hoover SL, et al. Applications and advantages of power motion-mode Doppler in acute posterior circulation cerebral ischemia. Stroke. 2008;39:1197–204.CrossRefPubMedGoogle Scholar
  76. 76.
    Turan TN, Cotsonis G, Lynn MJ, et al. Relationship between blood pressure and stroke recurrence in patients with intracranial arterial stenosis. Circulation. 2007;115:2969–75.CrossRefPubMedGoogle Scholar
  77. 77.
    Turan TN, Maidan L, Cotsonis G, et al. Failure of antithrombotic therapy and risk of stroke in patients with symptomatic intracranial stenosis. Stroke. 2009;40:505–9.CrossRefPubMedGoogle Scholar
  78. 78.
    Turk AS, Levy EI, Albuquerque FC, et al. Influence of patient age and stenosis location on wingspan in-stent restenosis. Am J Neuroradiol. 2008;29:23–7.CrossRefPubMedGoogle Scholar
  79. 79.
    U.S. Food and Drug Administration. 2013. FDA safety communication: narrowed indications for use for the Stryker Wingspan stent system.
  80. 80.
    Uehara T, Tabuchi M, Mori E. Frequency and clinical correlates of occlusive lesions of cerebral arteries in Japanese patients without stroke. Evaluation by MR angiography. Cerebrovasc Dis. 1998;8:267–72.CrossRefPubMedGoogle Scholar
  81. 81.
    Vajda Z, Miloslavski E, Güthe T, et al. Treatment of intracranial atherosclerotic arterial stenoses with a balloon-expandable cobalt chromium stent (Coroflex blue): procedural safety, efficacy, and midterm patency. Neuroradiology. 2010;52:645–51.CrossRefPubMedGoogle Scholar
  82. 82.
    Vajda Z, Güthe T, Perez MA, et al. Neurovascular in-stent stenosis: treatment with conventional and drug-eluting balloons. Am J Neuroradiol. 2011;32:1942–7.CrossRefPubMedGoogle Scholar
  83. 83.
    Vajda Z, Aguilar M, Göhringer T, et al. Treatment of intracranial atherosclerotic disease with a balloon- expandable paclitaxel eluting stent – procedural safety, efficacy and mid-term patency. Clin Neuroradiol. 2012a;22:227–33.CrossRefPubMedPubMedCentralGoogle Scholar
  84. 84.
    Vajda Z, Schmid E, Güthe T, et al. The modified Bose method for the endovascular treatment of intracranial atherosclerotic arterial stenoses using the Enterprise stent. Neurosurgery. 2012b;70:91–101.CrossRefPubMedGoogle Scholar
  85. 85.
    Vajda Z, Güthe T, Aguilar-Perez M, et al. Prevention of intracranial in-stent restenoses: predilatation with a drug eluting balloon, followed by the deployment of a self-expanding stent. Cardiovasc Intervent Radiol. 2013;36:346–52.CrossRefPubMedGoogle Scholar
  86. 86.
    Waddy SP, Cotsonis G, Lynn MJ, et al. Racial differences in vascular risk factors and outcomes of patients with intracranial atherosclerotic arterial stenosis. Stroke. 2009;40:719–25.CrossRefPubMedGoogle Scholar
  87. 87.
    Wang X, Lin WH, Zhao YD, et al. The effectiveness of dual antiplatelet treatment in acute ischemic stroke patients with intracranial arterial stenosis: a subgroup analysis of CLAIR study. Int J Stroke. 2013;8:663–8.CrossRefPubMedGoogle Scholar
  88. 88.
    Weimar C, Kraywinkel K, Diener HC, et al. Symptomatic intracranial atherosclerotic stenoses: prevalence and prognosis in patients with acute cerebral ischemia. Cerebrovasc Dis. 2010;30:188–93.CrossRefPubMedGoogle Scholar
  89. 89.
    Williams JE, Chimowitz MI, Cotsonis GA, et al. Gender differences in outcomes among patients with symptomatic intracranial arterial stenosis. Stroke. 2007;38:2055–62.CrossRefPubMedGoogle Scholar
  90. 90.
    Wong LKS. Global burden of intracranial atherosclerosis. Int J Stroke. 2006;1:158–9.CrossRefPubMedGoogle Scholar
  91. 91.
    Wong KS, Huang YN, Yang HB, et al. A door-to-door survey of intracranial atherosclerosis in Liangbei County, China. Neurology. 2007a;68:2031–4.CrossRefPubMedGoogle Scholar
  92. 92.
    Wong KS, Ngg PW, Tang A, et al. Prevalence of asymptomatic intracranial atherosclerosis in high-risk patients. Neurology. 2007b;68:2035–8.CrossRefPubMedGoogle Scholar
  93. 93.
    Yue Z, Yin Q, Xi G, et al. Comparison of BMSs with SES for symptomatic intracranial disease of the middle cerebral artery stenosis. Cardiovasc Intervent Radiol. 2011;24:54–60.CrossRefGoogle Scholar
  94. 94.
    Zaidat OO, Castonguay AC, Fitzsimmons BF, et al. Design of the Vitesse intracranial stent study for ischemic therapy (VISSIT) trial in symptomatic intracranial stenosis. J Stroke Cerebrovasc Dis. 2013;22:1131–9.CrossRefPubMedGoogle Scholar
  95. 95.
    Zaidat OO, Castoguay AC, Nguyen TN, et al. Impact of SAMMPRIS on the future of intracranial atherosclerotic disease management: polling results from the ICAD symposium at the international stroke conference. J Neurointervent Surg. 2014;6:225–30.CrossRefGoogle Scholar
  96. 96.
    Zhu SG, Zhang RL, Lu WH, et al. Predictive factors for in-stent restenosis after balloon-mounted stent placement for symptomatic intracranial atherosclerosis. Eur J Vasc Endovasc Surg. 2010;40:499–506.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Radiology and NeuroradiologyKlinikum PassauPassauGermany
  2. 2.Department of NeurologyKlinikum StuttgartStuttgartGermany
  3. 3.Department of NeuroradiologyKlinikum StuttgartStuttgartGermany

Personalised recommendations